HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

StriVectin’s #FightTechNeck Campaign Could Draw Millennials To Anti-Aging

This article was originally published in The Rose Sheet

Executive Summary

Prestige skin-care brand is positioning a range of StriVectin offerings as preventative against “tech neck,” or signs of aging that result from the repeated strain of checking mobile devices throughout the day. A comprehensive marketing campaign kicks off this fall with the potential to make anti-aging a more relevant category among Millennials.

You may also be interested in...



Lauder Projects Skin-Care Acceleration While Continuing To Ride Makeup Wave

Makeup drove the Estee Lauder Companies Inc.’s fiscal 2016 results and is expected to continue booming, but the firm also believes that skin-care growth will pick up as Millennials get more involved in the category.

FDA Warning Letter Recipients: Where Are Their Claims Now?

A key component of FDA’s enforcement strategy in the cosmetics space is monitoring companies’ websites for overreaching product claims and issuing warning letters accordingly. Examination of past offenders’ current sites and updated claims offers potential visibility into language the agency will and will not tolerate when it comes to promoting skin-care benefits.

Catterton Tries Its Luck On "Stretch-Mark Cream Turned Anti-Wrinkle Phenom"

Private equity firm Catterton Partners augments its cosmeceutical portfolio with the acquisition of an early trailblazer across the cosmetics/pharmaceuticals frontier, StriVectin

Topics

UsernamePublicRestriction

Register

LL1134420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel